6533b852fe1ef96bd12aa340

RESEARCH PRODUCT

Lower ST-elevation myocardial infarction incidence during COVID-19 epidemic in Northern Europe

Indulis KumsārsGeir ØYstein AndersenMatti NiemeläAndrejs ĒRglisJuha SinisaloLeif ThuesenJarkko PiuholaRisto KerkeläM. Juhani JunttilaMika Laine

subject

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)media_common.quotation_subject030204 cardiovascular system & hematologyScandinavian and Nordic CountriesTertiary Care Centers03 medical and health sciences0302 clinical medicineSt elevation myocardial infarctionHygieneRespiratory virus infectionPandemicFlu seasonMedicineHumanscardiovascular diseases030212 general & internal medicinemedia_commonRetrospective Studiesbusiness.industryIncidence (epidemiology)IncidenceCOVID-19Latvia3. Good healthsurgical procedures operativeST-elevation myocardial infarctionincidenceST Elevation Myocardial InfarctionbusinessCardiology and Cardiovascular MedicineDemography

description

We compared the ST elevation myocardial infarction (STEMI) incidence during COVID-19 pandemic (March 2020) to January-February 2020 and to same time period in earlier years 2017-2019 in five Nordic-Baltic tertiary centers. During 2017-2019, there were no marked differences in STEMI incidence between January, February and March. During 2020, there was an average drop of 32% in STEMI incidence in March. The isolation measures may decrease the risk for respiratory virus infection and contribute to the lower STEMI incidence and that we might benefit from firmer suggestions on hand hygiene and social distancing during flu season at least among high-risk individuals.

yearjournalcountryeditionlanguage
2020-09-18
10.1080/14017431.2020.1820563https://vbn.aau.dk/da/publications/e626e758-7ce8-4554-b117-b6c962c1cd79